ALX Oncology appoints Scott Garland as Chairman and Michael Listgarten as General Counsel
ALX Oncology has appointed Scott Garland as Chairman and Michael Listgarten as General Counsel. This executive shuffle strengthens the company's leadership team as it advances its clinical pipeline.
View filing at SEC.gov →